Wolverine Asset Management LLC Vertex Pharmaceuticals Inc Transaction History

Wolverine Asset Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$181.39 - $202.99 $215,672 - $241,355	-1,189 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$187.49 - $221.1 $102,182 - $120,499	545 Added 84.63%	1,189 $239,000
Q1 2021 May 13, 2021	BUY	$207.02 - $241.31 $120,485 - $140,442	582 Added 938.71%	644 $138,000
Q4 2020 Feb 12, 2021	BUY	$207.01 - $276.09 $12,834 - $17,117	62 New	62 $14,000
Q3 2020 Nov 13, 2020	SELL	$255.65 - $303.1 $1,789 - $2,121	-7 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$225.48 - $295.8 $1,578 - $2,070	7 New	7 $2,000
Q4 2017 Feb 14, 2018	SELL	$137.28 - $155.55 $3.02 Million - $3.42 Million	-21,969 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$148.13 - $162.24 $2.84 Million - $3.11 Million	19,169 Added 684.61%	21,969 $3.34 Million
Q2 2017 Aug 14, 2017	BUY	N/A	2,800	2,800 $360,000

1,724

221M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Asset Management LLC with notifications on news.